PBS “a national treasure,” says Medicines Australia, but needs stable framework

20 March 2014
canberra-big

In his address to the country at the National Press Club in Canberra yesterday, Chairman of Medicines Australia, Martin Cross, emphasised the sustainability of the Pharmaceutical Benefits Scheme and the importance of working closely with government.

“Australians enjoy amongst the highest life expectancy in the world thanks in large part to the medicines available through the PBS,” said Dr Cross, adding: “However, to ensure the future viability of the PBS, it is vital that we have a stable policy framework between government and the industry, despite the challenges we have faced in the past.”

Dr Cross also said pragmatic solutions are now required to ensure Australians continue to have universal, timely access to the latest medicines and the industry remains a strong contributor to the wealth as well as the health of the nation.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical